HERON THERAPEUTICS, INC. /DE/ company info

CIK 818033
IRS Number 942875566
State of incorporation DE
Business address 4242 CAMPUS POINT COURT, SUITE 200
None
SAN DIEGO
CA
92121
Mail address 4242 CAMPUS POINT COURT, SUITE 200
None
SAN DIEGO
CA
92121

Short summary

HERON THERAPEUTICS, INC. /DE/ is a California company, with head office located at 4242 Campus Point Court, Suite 200 San Diego, California 92121. In 2018 the company owned a total of 470.90 million USD worth of assets, including 460.06 million USD worth of current assets. 2017 was the year when the company amassed the most assets.

HERON THERAPEUTICS, INC. /DE/ Income Statement

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Research and development 7.807.268.2115.1732.7854.8361.18103.13138.58
Operating Expenses 11.5011.2411.7123.8354.4674.5696.93172.19225.33
Operating Income (Loss) -10.24-9.93-11.06-23.83-54.46-74.56-96.93-170.92-194.56
Interest expense 0.610.830.890.962.663.94
Other Nonoperating Income (Expense) 0.240.010.00-0.920.290.44-0.04
Income Tax Expense (Benefit) -0.12000000
Net income -10.03-7.35-11.81-23.35-55.28-76.37-97.59-173.14-197.48

HERON THERAPEUTICS, INC. /DE/ Balance Sheet

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Cash and cash equivalents 9.975.7421.3312.4434.85105.01171.5361.9430.28258.9353.93
Available-for-sale Securities, Current 012.7078.99164.03310.87
Accounts Receivable, Net, Current 18.6245.8953.63
Inventories 3.314.8027.2031.41
Property, Plant and Equipment, Gross 5.366.167.167.658.6011.6913.84
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 4.284.414.274.835.556.617.86
Other Assets, Noncurrent 0.030.130.150.130.130.130.260.430.25
Total assets 22.1214.2338.09108.64176.4685.73142.37510.56470.90
Current assets 21.8313.0035.21105.53173.4281.13136.35502.62460.06
Accounts payable 0.290.615.351.772.998.666.324.989.64
Total current liabilities 3.203.129.5910.7916.5927.8948.3078.6764.09
Deferred Revenue, Noncurrent
Total liabilities 3.233.3619.7473.30103.17
Common Stock, Value, Issued 0.402.003.060.290.360.390.540.780.78
Retained Earnings (Accumulated Deficit) -151.78-169.73-211.95-275.42-358.91-489.50-679.10-872.82-911.16
Accumulated Other Comprehensive Income (Loss), Net of Tax -0.00-0.01-0.03-0.04

HERON THERAPEUTICS, INC. /DE/ Cash Flow

Name [in Millions USD]20082009201020112012201320142015201620172018Trends
Net income -10.03-7.35-11.81-23.35-55.28-76.37-97.59-173.14-197.48
Depreciation and amortization 0.360.230.180.200.330.580.731.10
Depreciation 0.180.200.330.600.701.101.50
Depreciation and amortization 0.731.101.53
Deferred Income Tax Expense (Benefit)
Accounts receivable -0.140.060.111.9639.91
Inventories 5.344.77
Accounts payable -0.18-0.000.470.98-0.431.290.753.5111.96
Deferred revenue -0.64-0.09-0.271.101.66
Net Cash Provided by (Used in) Operating Activities -11.00-5.48-7.72-17.01-40.76-60.28-78.53-134.10-170.30
Payments to Acquire Property, Plant, and Equipment 0.000.080.510.971.691.441.093.142.55
Net Cash Provided by (Used in) Investing Activities 0.61-0.08-0.51-0.97-1.69-1.44-56.9614.887.74
Proceeds from Issuance of Common Stock 50.4957.8058.92
Net Cash Provided by (Used in) Financing Activities 8.010.0824.1053.5161.2362.11137.9957.46293.73
Cash and Cash Equivalents, Period Increase (Decrease) -2.37-5.4815.8735.5318.780.392.51-61.77131.17